Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Small Cell Lung Carcinoma 9 Carcinoma, Non-Small-Cell Lung 7 Sarcoma 5 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Thyroid Neoplasms 3 Nasopharyngeal Carcinoma 3 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Whole-Brain Radiotherapy 1 Stomach Neoplasms 1 Solid Tumors 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Proteinuria 1 Progression Free Survival(PFS) 1 Platinum-resistant Ovarian Cancer (PROC) 1 Ovarian Neoplasms 1 Lung Neoplasms 1 Leiomyosarcoma 1 HER2-Negative Breast Cancer 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Extensive Stage Lung Small Cell Cancer 1 Esophageal Neoplasms 1

Interventions

pembrolizumab 4 lenvatinib 3 Magnetic Resonance Spectroscopy 3 Specimen Handling 2 Nivolumab 2 Epirubicin 2 regorafenib 1 gallium 68 PSMA-11 1 enfortumab vedotin 1 anlotinib 1 amivantamab 1 abemaciclib 1 Tablets 1 Surveys and Questionnaires 1 Standard of Care 1 Radiosurgery 1 Pemetrexed 1 Observation 1 Ipilimumab 1 Imatinib Mesylate 1 Glutamate Carboxypeptidase II 1 Cyclophosphamide 1 Combined Modality Therapy 1 Carboplatin 1 CTLA-4 Antigen 1 Blood Specimen Collection 1 BMS-906024 1 68Ga-DKFZ-PSMA-11 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Adenoid Cystic × anlotinib × 1 year × Clear all

NCT07616141 2026-06-01

NAET4-SNACC

Eye & ENT Hospital of Fudan University

Phase 2 Not yet recruiting

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡